Record-breaking recovery, healthcare fraud dominance and what comes next

In January, the US Department of Justice (DOJ) announced that 2025 federal False Claims Act (FCA) settlements and judgments exceeded US$6.8 billion—the highest amount in a single year in the history of the FCA. That number more than doubled 2024’s US$3.3 billion in recoveries.

The 2025 FCA statistics also indicate that qui tam whistleblower activity is higher than ever. Last year, whistleblowers filed 1,297 qui tam lawsuits, marking the highest number ever in a single year (and 32 percent higher than 2024). Qui tam whistleblower lawsuits accounted for approximately US$5.3 billion—78.5 percent of all recoveries.

These statistics underscore the immense power of the FCA and its qui tam bounty hunter program, whether that power is in the hands of the DOJ, state attorneys general or qui tam whistleblower plaintiff attorneys. And, given this administration’s stated intention to attack all forms of fraud against the government, we expect the use of the FCA will only increase.

Increased focus on healthcare fraud

Healthcare fraud dominated FCA enforcement recoveries. Of the more than US$6.8 billion in settlements and judgments, over US$5.7 billion related to matters involving the health care industry—84 percent of all recoveries. The FCA recoveries were largely concentrated in three areas: managed care, prescription drugs and medically unnecessary care. The healthcare sector's prominence in FCA recovery underscores the vulnerability of these programs to fraud as well as the administration’s commitment to its continued investigation.

Beyond federal totals, the Norton Rose Fulbright 2026 Annual Litigation Trends Survey of healthcare executives and counsel indicate increased enforcement expectations and expanding risk areas. More than a third (35 percent) of healthcare counsel anticipate an uptick in regulatory and enforcement actions in 2026, a sentiment that aligns with the DOJ’s May 2025 announcement that healthcare fraud is its top white-collar enforcement priority, alongside heightened focus on other healthcare industry relevant areas like cybersecurity and data privacy, elder fraud, DEI-type programs and drug diversion/opioid issues. (Another trend contributing to that prediction was that survey respondents reported an 86 percent increase in actions by state attorneys general, with growing state-level False Claims Act filings, health program integrity initiatives, consumer protection and data privacy enforcement.)

Other FCA priorities

Beyond the usual volume of military-contractor-focused cases, this administration continued to emphasize national security and cybersecurity as FCA enforcement priorities. For example, the DOJ recovered over US$52 million among nine enforcement actions in cybersecurity cases—more than tripling settlements from each of the past two years. The DOJ also obtained more than 200 False Claims Act settlements and judgments collectively exceeding US$230 million for pandemic-related fraud for PPP loans, other government pandemic programs and COVID-19 testing.

A new FCA focus—export-import fraud

This administration has also prioritized FCA enforcement of fraud related to the evasion of tariffs and customs duties. In 2025, the DOJ obtained settlements against importers who attempted to misrepresent the type of goods imported from China to avoid antidumping and other duties, misrepresented items' country of origin and disguised items to evade duties. We expect these investigations to increase dramatically.

Conclusion

Despite healthcare fraud’s continued dominance, we expect significant prioritization of FCA enforcement in trade fraud and cybersecurity. With rising enforcement expectations across the government and the whistleblower plaintiffs’ bar, we believe that clients who normalize compliance vigilance in everyday operations will be best positioned to minimize FCA investigations and litigation and to keep strategic priorities on track.

card-grid-item, aem-sourced
Navigating international trade
and tariffs
Impacts of evolving trade regulations and compliance risks
/content/nrf-eds/en/insights/publications/navigating-international-trade-and-tariffs

Contact